Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse

View source ↗

Summary

An observational study of bevacizumab (Avastin) in patients with glioblastoma at first or second relapse has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Glioblastoma Multiforme | Status: COMPLETED